Prosecution Insights
Browse Companies Examiners Firms Draft Your Response
Home / Examiner: REN, HONG
Last updated: May 29, 2026

Examiner: REN, HONG

Tech Center 1600 • Art Units: 1647

This examiner grants 0% of resolved cases

Performance Statistics

—
Allow Rate
-60.0% vs TC avg
1
Total Applications
—
Interview Lift
0
Avg Prosecution Days
Based on 0 resolved cases, 2023–2026

Rejection Statute Breakdown

0%
§101 Eligibility
0%
§102 Novelty
0%
§103 Obviousness
0%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18142196 Anti-Interleukin-4 Receptor (IL-4R) Antibody Formulations Non-Final OA Regeneron Pharmaceuticals, Inc.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Data sourced from USPTO Patent File Wrapper (daily) and Office Action Archive (weekly). Analysis generated by IP Author.

Data: USPTO Patent File Wrapper (daily) • Office Action Archive (weekly) • 89M+ prosecution events

© 2026 IP Author — Browse Office Actions • Examiners • Companies • Firms

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month